QA: Pacira Biosciences Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001396814_2019_Pacira_Biosciences_Inc.pdf

Logs

warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': inf, 'aggregate_val': 421026000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}}

Graph

Absolute values for 0001396814, Pacira Biosciences Inc

  xvar xval
0 AssetsCurrent 477,969,000
1 IntangibleAssetsNetIncludingGoodwill 62,040,000
2 PropertyPlantAndEquipmentNet 108,670,000
3 remainder_Assets 40,674,000
4 LiabilitiesCurrent 60,661,000
5 LiabilitiesNoncurrent 16,874,000
6 remainder_Liabilities 290,592,000
7 CostOfGoodsAndServicesSold 86,845,000
8 SellingGeneralAndAdministrativeExpense 177,265,000
9 ResearchAndDevelopmentExpense 55,688,000
10 remainder_Expenses 1,610,000
11 remainder_Revenues 337,277,000
12 remainder_NetIncome -16,340,000
13 remainder_ComprehensiveNetIncome 174,000
  yvar yval
0 Assets 689,353,000
1 Liabilities 368,127,000
2 Expenses 321,408,000
3 Revenues 337,277,000
4 StockholdersEquity 321,226,000
5 NetIncome -471,000
6 ComprehensiveNetIncome -384,000
7 BaseVar 866,339,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.32
9 EconomicCapitalRatio 2.55

Edgar->Model Mapping

Feature Distribution

Change over Time